We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$310M
2
SPG icon
Simon Property Group
SPG
+$93.4M
3
FR icon
First Industrial Realty Trust
FR
+$90.7M
4
PSA icon
Public Storage
PSA
+$88.6M
5
DOC icon
Healthpeak Properties
DOC
+$58M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIRM icon
1176
Mirum Pharmaceuticals
MIRM
$6.69B
$3K ﹤0.01%
148
+59
+66% +$1.17K
MRUS
1177
DELISTED
Merus
MRUS
$3K ﹤0.01%
186
+61
+49% +$1.07K
NVAX icon
1178
Novavax
NVAX
$1.2B
$3K ﹤0.01%
291
– –
RGNX icon
1179
Regenxbio
RGNX
$607M
$3K ﹤0.01%
146
– –
SANA icon
1180
Sana Biotechnology
SANA
$863M
$3K ﹤0.01%
767
+216
+39% +$1.06K
SMMT icon
1181
Summit Therapeutics
SMMT
$9.86B
$3K ﹤0.01%
810
+476
+143% +$866
TNGX icon
1182
Tango Therapeutics
TNGX
$4.23B
$3K ﹤0.01%
+355
New +$2.5K
ALT icon
1183
Altimmune
ALT
$568M
$2K ﹤0.01%
136
– –
ALXO icon
1184
ALX Oncology
ALXO
$262M
$2K ﹤0.01%
138
– –
AMRN
1185
Amarin Corp
AMRN
$302M
$2K ﹤0.01%
67
– –
ARDX icon
1186
Ardelyx
ARDX
$1.24B
$2K ﹤0.01%
+754
New +$1.28K
AUPH icon
1187
Aurinia Pharmaceuticals
AUPH
$1.91B
$2K ﹤0.01%
528
– –
AVDL
1188
DELISTED
Avadel Pharmaceuticals
AVDL
$2K ﹤0.01%
245
+125
+104% +$877
BCAB icon
1189
BioAtla
BCAB
$5.63M
$2K ﹤0.01%
4
+2
+100% +$830
BNS icon
1190
Scotiabank
BNS
$106B
$2K ﹤0.01%
50
-100
-67% -$4.93K
CHRS icon
1191
Coherus Oncology
CHRS
$221M
$2K ﹤0.01%
262
– –
CSTL icon
1192
Castle Biosciences
CSTL
$721M
$2K ﹤0.01%
86
– –
DSGN icon
1193
Design Therapeutics
DSGN
$746M
$2K ﹤0.01%
162
– –
DYN icon
1194
Dyne Therapeutics
DYN
$4.25B
$2K ﹤0.01%
210
+60
+40% +$694
EDIT icon
1195
Editas Medicine
EDIT
$390M
$2K ﹤0.01%
277
+77
+39% +$845
ERAS icon
1196
Erasca
ERAS
$6.15B
$2K ﹤0.01%
354
– –
ETNB
1197
DELISTED
89bio
ETNB
$2K ﹤0.01%
+187
New +$1.68K
EWTX icon
1198
Edgewise Therapeutics
EWTX
$4.3B
$2K ﹤0.01%
254
+110
+76% +$1.03K
LKFT
1199
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2K ﹤0.01%
51
– –
HLVX
1200
DELISTED
HilleVax
HLVX
$2K ﹤0.01%
+134
New +$2.42K
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.